Insight Wealth Strategies LLC Trims Holdings in McKesson Corporation $MCK

Insight Wealth Strategies LLC reduced its stake in McKesson Corporation (NYSE:MCK) by 93.5% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 374 shares of the company’s stock after selling 5,351 shares during the quarter. Insight Wealth Strategies LLC’s holdings in McKesson were worth $287,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the stock. University of Texas Texas AM Investment Management Co. purchased a new stake in McKesson in the fourth quarter valued at approximately $25,000. Swiss RE Ltd. purchased a new position in shares of McKesson during the fourth quarter worth $26,000. State of Wyoming purchased a new position in shares of McKesson during the second quarter worth $29,000. Kingdom Financial Group LLC. acquired a new stake in shares of McKesson in the fourth quarter valued at $33,000. Finally, Birchwood Financial Partners Inc. acquired a new stake in shares of McKesson in the fourth quarter valued at $33,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

More McKesson News

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: J.P. Morgan reiterated a Buy rating on McKesson, adding to the bullish analyst support for the stock. McKesson Gets a Buy from J.P. Morgan
• Positive Sentiment: Citi maintained its Buy rating, reinforcing confidence in McKesson’s earnings outlook following its latest quarterly report. Citi Keeps Buy Rating on McKesson
• Positive Sentiment: McKesson recently exceeded quarterly earnings and revenue expectations, with EPS of $9.93 and revenue of $105.38 billion. Revenue increased 7.7% year over year, while fiscal 2027 EPS guidance remains $44.20–$45.00.
• Positive Sentiment: The company raised its quarterly dividend to $0.94 per share from $0.82, signaling confidence in cash generation and shareholder returns.
• Neutral Sentiment: Wells Fargo raised its price target to $933 from $812 but retained an Equal Weight rating, suggesting analysts see some additional upside while remaining cautious about valuation. Wells Fargo Raises McKesson Price Target
• Negative Sentiment: Director Bradley E. Lerman sold 301 shares worth approximately $268,600. The relatively small transaction may pressure sentiment but does not materially alter McKesson’s fundamentals.
• Negative Sentiment: McKesson’s strong rally has brought the stock near its 52-week high, increasing concerns that favorable earnings, analyst targets and growth expectations may already be reflected in the share price.

McKesson Trading Down 2.7%

Shares of MCK opened at $877.21 on Thursday. McKesson Corporation has a twelve month low of $659.86 and a twelve month high of $999.00. The firm’s fifty day simple moving average is $809.56 and its 200-day simple moving average is $842.36. The firm has a market capitalization of $102.27 billion, a price-to-earnings ratio of 23.47, a PEG ratio of 1.77 and a beta of 0.30.

McKesson (NYSE:MCK) last issued its earnings results on Wednesday, August 5th. The company reported $9.93 EPS for the quarter, topping analysts’ consensus estimates of $9.56 by $0.37. The firm had revenue of $105.38 billion during the quarter, compared to the consensus estimate of $103.88 billion. McKesson had a net margin of 1.12% and a negative return on equity of 253.21%. The company’s revenue was up 7.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $8.26 earnings per share. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. On average, analysts predict that McKesson Corporation will post 44.65 earnings per share for the current fiscal year.

McKesson Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Tuesday, September 1st will be issued a dividend of $0.94 per share. This is a positive change from McKesson’s previous quarterly dividend of $0.82. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $3.76 dividend on an annualized basis and a yield of 0.4%. McKesson’s dividend payout ratio (DPR) is presently 8.78%.

Insider Buying and Selling at McKesson

In related news, Director Bradley E. Lerman sold 301 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $892.33, for a total value of $268,591.33. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Thomas L. Rodgers sold 2,388 shares of the company’s stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $761.09, for a total transaction of $1,817,482.92. Following the completion of the transaction, the executive vice president owned 3,090 shares of the company’s stock, valued at approximately $2,351,768.10. The trade was a 43.59% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders sold 29,049 shares of company stock worth $22,530,626. Corporate insiders own 0.06% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. TD Cowen increased their target price on McKesson from $989.00 to $1,006.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th. Wells Fargo & Company lifted their target price on McKesson from $812.00 to $933.00 and gave the company an “equal weight” rating in a research report on Tuesday. Wall Street Zen lowered shares of McKesson from a “buy” rating to a “hold” rating in a research note on Saturday, June 27th. JPMorgan Chase & Co. reduced their price target on shares of McKesson from $1,107.00 to $1,015.00 and set an “overweight” rating on the stock in a research report on Friday, May 8th. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $875.00 price objective on shares of McKesson in a research note on Friday, May 8th. Fourteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $977.00.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.